根据名称进行药物检索

Zolmitriptan ODT与心血管疾病

Zolmitriptan ODT与心血管疾病安全配伍检测的结果。

检测结果:

Zolmitriptan ODT <> 心血管疾病

现实性: 23.07.2019 评论家: 医学副博士Shkutko P.M., in

通过权威的信息来源 Drugs.com、Rxlist.com、Webmd.com、Medscape.com，在进行所选药物与这种伴发疾病互相作用检测时，发现一些会产生负面影响或对身体危害的禁忌症及副作用。

用户:

使用5-羟色胺受体(5-HT1)激动是禁忌的患者中的一个历史或当前的症状或标志的局部缺血性心脏、血管和/或周围的血管疾病。此外，这些药物不应使用的患者的任何其他重要基础的心血管疾病或不受控制的高血压。 5-HT1激动剂，可能会导致血管痉挛性反应，包括冠状动脉血管痉挛、周围的血管缺血，结肠局部缺血。一些严重不利的心脏活动，包括急性心肌梗塞心律失常、心脏病和死亡的已报告内的几个小时以下的行政管理5-HT1激动剂，在某些情况下甚至在病人之前没有历史或调查结果的冠状动脉疾病(計算機輔助設計)。显着升高血压力，包括高血压的危机，也已经报告了在极少数情况下，在患者和没有历史高血压，如有短暂增加血压和末稍血管抗性。脑血管的事件包括脑出血，蛛网膜下出血，以及中风，一些造成伤亡。然而，关系到5-HT1激动是不确定的，在一些情况下，脑血管的事件可能已经主要在那里症状被误认为是偏头痛。

来源

Ottervanger JP, Paalman HJ, Boxma GL, Stricker BH "Transmural myocardial infarction with sumatriptan." Lancet 341 (1993): 861-2
Kelly KM "Cardiac arrest following use of sumatriptan." Neurology 45 (1995): 1211-3
"Product Information. Axert (almotriptan)" Pharmacia and Upjohn, Kalamazoo, MI.
Boyd IW, Rohan AP "Sumatriptan-induced chest pain." Lancet 344 (1994): 1704-5
Ottervanger JP, van Witsen TB, Valkenburg HA, Stricker BH "Postmarketing study of cardiovascular adverse reactions associated with sumatriptan." BMJ 307 (1993): 1185
"Product Information. Zomig (zolmitriptan)." Zeneca Pharmaceuticals, Wilmington, DE.
"Product Information. Amerge (naratriptan)." Glaxo Wellcome, Research Triangle Park, NC.
Dooley M, Faulds D "Rizatriptan - A review of its efficacy in the management of migraine." Drugs 58 (1999): 699-723
MacLean MR, Smith GC, Templeton AG "Adverse reactions associated with sumatriptan." Lancet 341 (1993): 1092
Dulli DA "Naratriptan: an alternative for migraine." Ann Pharmacotherapy 33 (1999): 704-11
"Product Information. Frova (frovatriptan)." Endo Laboratories LLC, Chadds Ford, PA.
Plosker GL, Mctavish D "Sumatriptan - a reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache." Drugs 47 (1994): 622-51
Willett F, Curzen N, Adams J, Armitage M "Coronary vasospasm induced by subcutaneous sumatriptan." BMJ 304 (1992): 1415
Curtin T, Brooks AP, Roberts JA "Cardiorespiratory distress after sumatriptan given by injection." BMJ 305 (1992): d713-4
Visser WH, Jaspers NMWH, Devriend RHM, Ferrari MD "Chest symptoms after sumatriptan: a two-year clinical practice review in 735 consecutive migraine patients." Cephalalgia 16 (1996): 554-9
"Product Information. Maxalt (rizatriptan)." Merck & Co, Inc, West Point, PA.
Cavazos JE, Caress JB, Chilukuri VR, Devlin T, Gray L, Hurwitz BJ "Sumatriptan-induced stroke in sagittal sinus thrombosis." Lancet 343 (1994): 1105-6
"Product Information. Relpax (eletriptan)." Pfizer U.S. Pharmaceuticals, New York, NY.
"Product Information. Imitrex (sumatriptan)." Glaxo Wellcome, Research Triangle Park, NC.
Mueller L, Gallagher RM, Ciervo CA "Vasospasm-induced myocardial infarction with sumatriptan." Headache 36 (1996): 329-31
Morgan DR, Trimble M, McVeigh GE "Atrial fibrillation associated with sumatriptan." Br Med J 321 (2000): 275
Ottervanger JP, Vanwitsen TB, Valkenburg HA, Grobbee DE, Stricker BHC "Adverse reactions attributed to sumatriptan - a postmarketing study in general practice." Eur J Clin Pharmacol 47 (1994): 305-9
Visser WH, Devriend RHM, Jaspers NMWH, Ferrari MD "Sumatriptan in clinical practice: a 2-year review of 453 migraine patients." Neurology 47 (1996): 46-51